Andrew Zhu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript

Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Czech republicUnited statesAndrew zhuLouise chenYigal nochomovitzJosh smileyHarald reinhartLinhai zhao goldman sachsJonathan wangChristine chiouJack linJonathan changAnupam ramaYajing chenMichael yeeRafael amado

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongAndrew zhuBristol myers squibbEfgartigimod fcrnXanomeline trospium karSimcere zaimingJosh smileyZai lab limitedChina national reimbursement drug listExchange commissionPfizer incSchizophrenia international research societyNational medical products administrationZai lab forwardDrug administration

I-Mab Biopharma (IMAB) to Divest Assets and Business Operations in China

I-Mab Biopharma (IMAB) to Divest Assets and Business Operations in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongRaj kannanShuai chenRichard yehAndrew zhuJingwu zangJoseph skeltonPamela kleinBiopharma co ltdHangzhou companyBiopharma hong kong limitedi mabChairperson of the companyAmneal pharmaceuticals incBiopharma hangzhou co ltdCantor fitzgeraldI mab biopharma

I-Mab to Divest Chinese Unit for Up to $80M

By Rob Curran Biotech concern I-Mab agreed to sell its Chinese unit to affiliate I-Mab Biopharma (Hangzhou)for up to $80 million after contingencies, and it.

San diegoUnited statesHong kongBiopharma hong kongJoseph skeltonPamela kleinJingwu zangRichard yehRaj kannanRob curranAndrew zhuI mab biopharmaI mab chief executive raj kannanI mab biopharma hong kongI mab hong kongArticle normal

I-Mab Signs Agreement to Divest its Assets and Business Operations in China

ROCKVILLE, Md., Feb. 7, 2024 /PRNewswire/ I-Mab (the "Company") (NASDAQ: IMAB), a global biotech company exclusively focused on bringing highly

United statesSan diegoHong kongGigi fengJoseph skeltonTyler ehlerAndrew zhuRichard yehShuai chenJingwu zangRaj kannanPamela kleinBiopharma hangzhou co ltdExchange commissionChairperson of the companyBiopharma hong kong limitedi mab